Why Fortress Biotech (FBIO) Stock Is Getting Hammered
Why Fortress Biotech (FBIO) Stock Is Getting Hammered
The offerings will raise approximately $8 million in gross proceeds, aimed at general corporate use. Fortress Biotech Inc (NASDAQ:FBIO) shares are trading lower by 18.5% to $1.49 Friday afternoon after the company announced the pricing of a $8 million registered direct offering and concurrent private placements.
fortress biotech公司（納斯達克:FBIO）股價下跌18.5%，至1.49美元，週五下午該公司宣佈了價值800萬美元的註冊直接發行和同時進行的定向增發。
What Happened: Fortress Biotech announced on Thursday that it entered into securities purchase agreements with healthcare-focused institutional investors to sell 3,939,394 shares of common stock at $1.65 per share in a direct offering.
發生了什麼：Fortress Biotech週四宣佈，已與以醫療爲重點的機構投資者簽訂證券購買協議，以每股1.65美元的價格出售3939394股普通股，進行了直接發行。
Additionally, the company issued warrants to purchase up to 3,939,394 shares at $1.84 per share, exercisable in six months, expiring in five and a half years. In a separate private placement, the company's Chairman, CEO and President purchased 763,359 shares and warrants at $1.84 per share.
此外，該公司發行認股權證，以每股1.84美元的價格購買3939394股，行使期爲六個月，期限爲五年半。在另一項定向增發中，該公司的董事長，首席執行官和總裁以每股1.84美元的價格購買了763359股和認股權證。
The offerings will raise approximately $8 million in gross proceeds, aimed at general corporate use. A.G.P./Alliance Global Partners is acting as the sole placement agent, and the offerings are expected to close around September 23, 2024.
這些發行將募集約800萬美元的總收益，用於一般企業用途。A.G.P./Alliance Global Partners將充當唯一的配售代理，預計這些發行將於2024年9月23日左右關閉。
Read Also: How Apple Stock Could Gain From Friday's S&P 500 Rebalancing: What Investors Should Know
閱讀更多：蘋果股票如何從週五的標準普爾500指數重新平衡中獲益：投資者應知道的事
Should I Sell My FBIO Stock?
我應該賣出我的FBIO股票嗎？
When deciding to hold on to or sell a stock, investors should consider their time horizon, unrealized gains and total return.
在決定持有或出售股票時，投資者應考慮他們的投資期限、未實現收益和總回報。
Shares of Fortress Biotech have decreased by 67.86% in the past year. An investor who bought shares of Fortress Biotech at the beginning of the year would take a loss of $1.22 per share if they sold it today. The stock has fallen 29.9% over the past month, meaning an investor who bought shares on Aug. 1 would see a capital loss of $0.44.
Fortress Biotech的股價在過去一年中已下跌了67.86%。一個投資者如果在年初購買了Fortress Biotech的股票，今天賣出將損失1.22美元。股價在過去一個月下跌了29.9%，這意味着一個於8月1日購買股票的投資者將看到0.44美元的資本損失。
Fortress Biotech shares have an all-time high of $54.75, representing 3637.2% upside from current levels.
fortress biotech股價創下歷史最高紀錄，達到54.75美元，比當前水平高出3637.2%。
Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. Fortress Biotech stock currently has an RSI of 48.73, indicating neutral conditions.
投資者也可以考慮市場動態。相對強弱指數可以用來指示股票是否被過度買入或賣出。fortress biotech股票目前的RSI爲48.73，表明中立情況。
For access to advanced charting and analysis tools and stock data, check out Benzinga PRO. Try it for free.
獲取先進的圖表和分析工具以及股票數據，請查看Benzinga PRO。免費試用。
FBIO has a 52-week high of $5.28 and a 52-week low of $1.25.
FBIO的52周最高價爲5.28美元，52周最低價爲1.25美元。
譯文內容由第三人軟體翻譯。